Showing results (1241-1250 of 1,547) with videos related to
Sort By:
Pageof 155
Nature Medicine|April 28, 2022
Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CASmita S Chandran, Jiaqi Ma, Martin G Klatt, et al.Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi = Chinese Journal of Schistosomiasis Control|July 27, 2022
[Analysis of the new WHO guideline to accelerate the progress towards elimination of schistosomiasis in China]Z Y Guo, J X Feng, L J Zhang, et al.Neuro-Oncology|March 19, 2009
Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08)Patrick Y Wen, W K Alfred Yung, Kathleen R Lamborn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2020
Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent GlioblastomaLakshmi Nayak, Annette M Molinaro, Katherine Peters, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2022
Circulating Immune Cell and Outcome Analysis from the Phase II Study of PD-L1 Blockade with Durvalumab for Newly Diagnosed and Recurrent GlioblastomaLakshmi Nayak, Nathan Standifer, Jorg Dietrich, et al.Journal of the National Cancer Institute|January 17, 2019
The Genomic Landscape of Mucinous Breast CancerFresia Pareja, Ju Youn Lee, David N Brown, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 19, 2018
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 AntagonismVarun V Prabhu, Neel S Madhukar, Coryandar Gilvary, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 11, 2025
Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical TrialAyal A Aizer, Shyam K Tanguturi, Diana D Shi, et al.Neuro-Oncology|August 29, 2014
Brain Malignancy Steering Committee clinical trials planning workshop: report from the Targeted Therapies Working GroupBrian M Alexander, Evanthia Galanis, W K Alfred Yung, et al.Neuro-Oncology|June 28, 2022
Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directionsAyal A Aizer, Nayan Lamba, Manmeet S Ahluwalia, et al.Pageof 155